Search

Your search keyword '"Vakar-Lopez, Funda"' showing total 308 results

Search Constraints

Start Over You searched for: Author "Vakar-Lopez, Funda" Remove constraint Author: "Vakar-Lopez, Funda" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
308 results on '"Vakar-Lopez, Funda"'

Search Results

1. High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker.

2. Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.

3. Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study

4. Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.

7. Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression

8. A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer

9. Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: a Multi-Center Retrospective Study

10. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging

11. Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage.

12. MP35-18 AGREEMENT BETWEEN TRANSURETHRAL RESECTION OF BLADDER TUMOR (TURBT) AND RADICAL CYSTECTOMY (RC) PATHOLOGY IN PATIENTS WITH BLADDER CANCER SUBTYPE HISTOLOGY

13. Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program

15. Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.

16. Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy

18. Characterization of HOXB13 expression patterns in localized and metastatic castration‐resistant prostate cancer

20. Characterization of HOXB13 expression patterns in localized and metastatic castration‐resistant prostate cancer.

26. Data from Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

27. Supplementary Data from Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

28. A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer

31. PD10-06 A PHASE 1/2 STUDY OF RAPAMYCIN AND CISPLATIN/GEMCITABINE FOR TREATMENT OF PATIENTS (PTS) WITH MUSCLE-INVASIVE BLADDER CANCER (NCT01938573)

32. PD53-09 ANTIBODY DRUG CONJUGATES AND VARIANT HISTOLOGY MUSCLE-INVASIVE BLADDER CANCER: ARE THE TARGETS PRESENT IN PRIMARY AND/OR METASTATIC TUMORS?

33. MP06-05 UROTHELIAL CANCER RAPID AUTOPSY PROGRAM: BIOSPECIMENS AND PATIENT-DERIVED PRECLINICAL MODELS

34. Corrigendum to: Mechanistic target of rapamycin (mTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy

37. Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy

41. Primary angiosarcoma of the bladder

43. Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey

49. Abstract PR06: Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy

50. HPV16induces penile intraepithelial neoplasia and squamous cell carcinoma in transgenic mice: first mouse model forHPV‐related penile cancer

Catalog

Books, media, physical & digital resources